Literature DB >> 23464691

Pathology of invasive breast disease.

Adriana D Corben1.   

Abstract

Invasive breast cancers constitute a heterogeneous group of lesions. Although the most common types are ductal and lobular, this distinction is not meant to indicate the site of origin within the mammary ductal system. The main purpose of the identification of specific types of invasive breast carcinoma is to refine the prediction of likely behavior and response to treatment also offered by the other major prognostic factors, including lymph node stage, histologic grade, tumor size, and lymphovascular invasion.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23464691     DOI: 10.1016/j.suc.2013.01.003

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  9 in total

1.  Invasive Lobular Carcinoma Has Worse Outcome Compared with Invasive Ductal Carcinoma in Stage IV Breast Cancer with Bone-Only Metastasis.

Authors:  Yunbo Luo; Aimin Ma; Shengkai Huang; Yinghua Yu
Journal:  Breast Care (Basel)       Date:  2021-11-26       Impact factor: 2.268

2.  Loss of E-cadherin Induces IGF1R Activation and Reveals a Targetable Pathway in Invasive Lobular Breast Carcinoma.

Authors:  Ashuvinee Elangovan; Jagmohan Hooda; Laura Savariau; Susrutha Puthanmadhomnarayanan; Megan E Yates; Jian Chen; Daniel D Brown; Priscilla F McAuliffe; Steffi Oesterreich; Jennifer M Atkinson; Adrian V Lee
Journal:  Mol Cancer Res       Date:  2022-09-02       Impact factor: 6.333

3.  MicroRNA-126 expression in the peripheral white blood cells of patients with breast and ovarian cancer is a potential biomarker for the early prediction of cancer risk in the carriers of methylated BRCA1.

Authors:  Maram Al-Showimi; Nujoud Al-Yousef; Wejdan Alharbi; Sara Alkhezayem; Osama Almalik; Hamed Alhusaini; Amani Alghamdi; Nisreen Al-Moghrabi
Journal:  Oncol Lett       Date:  2022-06-22       Impact factor: 3.111

4.  A Comparison of the Clinicopathological Features, Metastasis Sites and Survival Outcomes of Invasive Lobular, Invasive Ductal and Mixed Invasive Ductal and Lobular Breast Carcinoma.

Authors:  Nüvit Duraker; Semih Hot; Arzu Akan; Pınar Özay Nayır
Journal:  Eur J Breast Health       Date:  2020-01-01

5.  Locoregional therapy in luminal-like and HER2-enriched patients with de novo stage IV breast cancer.

Authors:  Peng-Yu Chen; Skye Hung-Chun Cheng; Chen-Fang Hung; Ben-Long Yu; Chii-Ming Chen
Journal:  Springerplus       Date:  2013-11-01

6.  IL-32 promotes breast cancer cell growth and invasiveness.

Authors:  Shouman Wang; Feiyu Chen; Lili Tang
Journal:  Oncol Lett       Date:  2014-10-27       Impact factor: 2.967

7.  In vivo near-infrared imaging of ErbB2 expressing breast tumors with dual-axes confocal endomicroscopy using a targeted peptide.

Authors:  Zhenghong Gao; Gaoming Li; Xue Li; Juan Zhou; Xiyu Duan; Jing Chen; Bishnu P Joshi; Rork Kuick; Basma Khoury; Dafydd G Thomas; Tina Fields; Michael S Sabel; Henry D Appelman; Quan Zhou; Haijun Li; Ken Kozloff; Thomas D Wang
Journal:  Sci Rep       Date:  2017-10-31       Impact factor: 4.379

Review 8.  Proteomic approaches in biomarker discovery: new perspectives in cancer diagnostics.

Authors:  Petra Hudler; Nina Kocevar; Radovan Komel
Journal:  ScientificWorldJournal       Date:  2014-01-14

9.  A recapitulative three-dimensional model of breast carcinoma requires perfusion for multi-week growth.

Authors:  Kayla F Goliwas; Lauren E Marshall; Evette L Ransaw; Joel L Berry; Andra R Frost
Journal:  J Tissue Eng       Date:  2016-07-29       Impact factor: 7.813

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.